Pharmaceutical Technology on MSN7d
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US Food and Drug Administration (FDA) has approved scPharmaceuticals’ supplemental new drug application (sNDA) for ...
Nature14d
Proximal Renal Tubular Acidosis. A Defect in Bicarbonate Reabsorption with Normal Urinary Acidification
In fig. 5, rates of reabsorption and excretion of bicarbonate, expressed as mmoles/100 ml glomerular filtrate (GF) are plotted against serum bicarbonate concentration in mmoles/liter. Data from 2 ...
MPR8d
Galzin Now Available for Maintenance Treatment of Wilson Disease
Galzin ® (zinc acetate capsules) is now available for maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent, according to Eton Pharmaceuticals.